OCT 25, 2016 12:34 PM PDT

New Compound in Onions Halts Ovarian Cancer Proliferation

WRITTEN BY: Xuan Pham
A study from the University of Japan finds that certain compounds in onions have anticancer effects against ovarian cancer. Onion lovers rejoice!
 
Known for its polarizing taste and pungent smell, onions are high in many vitamins and antioxidants. Studies have linked onions to health benefits, like strengthening the immune system, lowering blood pressure, and even fighting cancer.
 

One compound, aptly called onionin A (ONA), was recently identified by researchers at the Kumamoto University in Japan. ONA is high in sulfur and researchers believed it can squelch a tumor microenvironment. In particular, the team was especially interested in how ONA may act on epithelia ovarian cancer (EOC), which is often associated with tumor-associated macrophages.
 
In pre-clinical trials, the researchers treated EOC cells with the onion-derived compound. They found that ONA directly suppressed cancer cell proliferation. Furthermore, the effect appeared synergistic when combined with other anticancer drugs.
 
When the compound was used to treat a mouse model of EOC, the team found increased survival time. Molecular research also revealed that the signals for chemo-resistance was abolished with the application of ONA, suggesting a mechanism for how ONA acts on cancer cells.
 
The team concluded that “ONA is considered useful for the additional treatment of patients with ovarian cancer owing to its suppression of the pro-tumor activation of [tumor-associated macrophages] and direct cytotoxicity against cancer cells."
 

Of note, this first study to investigate the effect of an onion compound in ovarian cancer did not find any side effects in the animals. This, combined with the promising positive anticancer effects, could mean a faster path to human clinical trials and treatment.
 
Ovarian cancers have one of the highest mortality rates, ranking fifth in cancer deaths among women. Of the 22,000 new estimated cases of ovarian cancer this year, only 10-15 percent of patients will be successfully treated. Unfortunately, in the large percent of remaining patients, the cancer doesn’t respond to treatment, or will inevitably return with a vengeance. As such, research into low risk, natural compounds like ONA may be fruitful to fight this deadly disease.

Additional sources: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JAN 20, 2020
Cancer
JAN 20, 2020
Did you know these non-cancer drugs can also fight cancer?
A study from MIT. Harvard and the Dana-Farber Cancer Institute has concluded that almost 50 existing non-oncological drugs have anti-cancer properties capa...
FEB 02, 2020
Cell & Molecular Biology
FEB 02, 2020
New T Cell Therapy is a Universal Approach to Target Cancer
For years, researchers have been trying to harness the power of the assassins of the immune system - killer T cells....
FEB 08, 2020
Cancer
FEB 08, 2020
Magic mushrooms help cancer patients' depression
A follow-up to a study originally published in the Journal of Psychopharmacology in 2016 reports the long-term benefits of a one-time, single-dose tre...
MAR 16, 2020
Cancer
MAR 16, 2020
Aspirin associated with reduced risk of liver cancer
A study published in the New England Journal of Medicine from scientists collaborating from the Karolinska Institutet, in Sweden, and Massachusetts General...
MAR 23, 2020
Genetics & Genomics
MAR 23, 2020
Diagnosing Cancer by Looking for Microbial DNA in the Blood
Liquid biopsies aim to diagnose a disease with only a bit of biological fluid, usually blood....
MAR 28, 2020
Cancer
MAR 28, 2020
The Not So Minor Genetic Players in Head and Neck Cancers
Head and neck squamous cell carcinomas (HNSCC) are among the most prevalent cancers among smokers, linked to alcohol consumption, and the human papillomavi...
Loading Comments...